| Literature DB >> 34480175 |
Natasha Toleska Dimitrovska1, Feichao Bao2, Ping Yuan3, Shoujun Hu4, Xiao Chu5, Wentao Li2.
Abstract
OBJECTIVES: When lung cancer evolves from a large, centrally located mass to small, peripherally located pulmonary nodules, such as ground glass nodules, segmentectomy offers a reasonable method by which to save lung parenchyma without eliciting compromising oncological effects. To master these techniques, it is important to analyse the learning curve of surgeons. Therefore, the aim of the present study was to analyse the learning curve for two-port video-assisted thoracoscopic surgery (VATS) segmentectomy in our institution.Entities:
Keywords: Learning curve; Segmentectomy; Video-assisted thoracoscopic surgery
Mesh:
Year: 2022 PMID: 34480175 PMCID: PMC8922683 DOI: 10.1093/icvts/ivab236
Source DB: PubMed Journal: Interact Cardiovasc Thorac Surg ISSN: 1569-9285
Figure 1:(A) Positions of the surgical ports for two-port video-assisted thoracoscopic surgery segmentectomy (before surgery). (B) Positions of the surgical ports for two-port VATS segmentectomy (after surgery).
Figure 2:(A) Two-port video-assisted thoracoscopic surgery (VATS) segmentectomy (extrathoracic view). (B) Two-port VATS segmentectomy (intrathoracic view). (C) The dorsal artery of the left lower lobe was dissected in two-port VATS left lower lobe dorsal segmentectomy.
Figure 3:Raw OTs plotted in chronological case order. OT: operative time.
Figure 4:Cumulative sum plot for two-port video-assisted thoracoscopic surgery segmentectomy. Patients 1–27 constitute the ascending slope of the curve [initial learning phase (phase 1)], patients 28–54 constitute the plateau part of the curve [increased competence phase (phase 2)] and patients 55–86 constitute the descending slope [experienced phase (phase 3)].
Interphase comparisons of patient characteristics and operative parameters in all cases
| Phase 1 ( | Phase 2 ( | Phase 3 ( | ||
|---|---|---|---|---|
| Sex, | 0.45 | |||
| Female | 15 | 19 | 18 | |
| Male | 12 | 8 | 14 | |
| Age (years), mean ± SD | 59.8 ± 11.5 | 57.8 ± 10.7 | 58.9 ± 10.0 | 0.80 |
| Comorbidity, | 0.56 | |||
| Hypertension | 8 | 7 | 9 | |
| Diabetes | 6 | 3 | 4 | |
| Others | 0 | 2 | 2 | |
| FEV1% Pred (%), mean ± SD | 87.2 ± 23.3 | 85.7 ± 27.0 | 83.8 ± 14.8 | 0.51 |
| Surgical level, | 0.71 | |||
| Simple | 11 | 9 | 14 | |
| Complex | 16 | 18 | 18 | |
| OT (min), mean ± SD | 105.5 ± 20.0 | 84.6 ± 14.8 | 62.8 ± 11.1 | <0.001 |
| EBL (ml), mean ± SD | 206.7 ± 63.3 | 173.3 ± 69.9 | 125.0 ± 67.2 | <0.001 |
| Conversion, | 2 | 0 | 2 | 0.38 |
| Morbidity, | 3 | 4 | 3 | 0.84 |
| Mortality, | 0 | 0 | 0 | NA |
| Pathology, | 0.90 | |||
| Malignant | 24 | 25 | 29 | |
| Benign | 3 | 2 | 3 | |
| Oncological status, | 0.93 | |||
| AIS | 10 | 7 | 13 | |
| MIA | 7 | 9 | 5 | |
| IAC | 6 | 7 | 9 | |
| SCC | 1 | 2 | 2 | |
| AAH | 1 | 1 | 2 | |
| Tuberculoma | 2 | 1 | 1 | |
| Tumour size, mean ± SD | 1.89 ± 1.13 | 1.81 ± 1.02 | 1.73 ± 1.15 | 0.87 |
AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; EBL: estimated blood loss; FEV: forced expiratory volume; IAC: invasive adenocarcinoma; MIA: microinvasive adenocarcinoma; NA: not applicable; OT: operative time; SCC: squamous cell carcinoma.
Comparison of patient characteristics and operative parameters between cases of simple and complex segmentectomy
| Simple | Complex | ||
|---|---|---|---|
| Sex, | |||
| Male | 18 | 16 | |
| Female | 16 | 36 | 0.067 |
| Age (years), mean ± SD | 56.8 ± 8.6 | 60.2 ± 11.6 | 0.15 |
| Comorbidity, | 0.85 | ||
| Hypertension | 9 | 15 | |
| Diabetes | 3 | 9 | |
| Others | 1 | 3 | |
| FEV1% Pred (%), mean ± SD | 95.0 ± 17.0 | 85.9 ± 25.6 | 0.24 |
| OT (min), mean ± SD | 73.7 ± 16.7 | 89.1 ± 25.3 | 0.003 |
| EBL (ml), mean ± SD | 139.7 ± 53.3 | 182.9 ± 81.5 | 0.007 |
| Conversion, | 0 | 4 | 0.26 |
| Morbidity, | 3 | 7 | 0.76 |
| Mortality, | 0 | 0 | NA |
| Oncological status, | 0.73 | ||
| AIS | 13 | 17 | |
| MIA | 8 | 13 | |
| IAC | 6 | 16 | |
| SCC | 3 | 2 | |
| AAH | 2 | 2 | |
| Tuberculoma | 2 | 2 | |
| Tumour size, mean ± SD | 1.70 ± 1.33 | 1.97 ± 0.91 | 0.48 |
AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; EBL: estimated blood loss; FEV: forced expiratory volume; IAC: invasive adenocarcinoma; MIA: microinvasive adenocarcinoma; NA: not applicable; OT: operative time; SCC: squamous cell carcinoma.